SCHEMBL16539076

SCHEMBL16539076

COc1cc(C(=O)/C=C/c2cc(-c3ccccc3)n[nH]2)cc(OC)c1OC

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TNFRSF1A P19438 3/20 0.62
▸ MEN1 O00255 2/20 0.56
▸ KMT2A Q03164 2/20 0.56
▸ ABCG2 Q9UNQ0 2/20 0.55
▸ ABCB1 P08183 5/20 0.55
▸ ALDH1A1 P00352 1/20 0.53
▸ HPGD P15428 1/20 0.53
▸ KRAS P01116 1/20 0.52
▸ LMNA P02545 1/20 0.50
▸ PKM P14618 1/20 0.50
▸ MAPK1 P28482 1/20 0.50
▸ TUBB1 Q9H4B7 5/20 0.49
▸ TUBB4A P04350 2/20 0.49
▸ TUBB P07437 2/20 0.49
▸ TUBA3C P0DPH7 2/20 0.49
▸ TUBA1B P68363 2/20 0.49
▸ TUBA4A P68366 2/20 0.49
▸ TUBB4B P68371 2/20 0.49
▸ TUBB3 Q13509 2/20 0.49
▸ TUBB2A Q13885 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16539079 1.00 TNFRSF1A (0.62) TNFRSF1AMEN1KMT2AABCG2ABCB1
SCHEMBL18671601 0.92 TNFRSF1A (0.52) TNFRSF1AMEN1KMT2AABCG2ABCB1
SCHEMBL16539425 0.91 TNFRSF1A (0.55) TNFRSF1AMEN1KMT2AABCG2ABCB1
SCHEMBL16539424 0.91 TNFRSF1A (0.55) TNFRSF1AMEN1KMT2AABCG2ABCB1
SCHEMBL16539126 0.90 ABCG2 (0.57) TNFRSF1AABCG2ABCB1KRASTUBB1
SCHEMBL16539128 0.90 ABCG2 (0.57) TNFRSF1AABCG2ABCB1KRASTUBB1
SCHEMBL17924168 0.90 KRAS (0.56) TNFRSF1AMEN1KMT2AABCG2ABCB1
SCHEMBL16547775 0.90 KRAS (0.56) TNFRSF1AMEN1KMT2AABCG2ABCB1
SCHEMBL17924234 0.89 ABCG2 (0.53) TNFRSF1AABCG2ABCB1KRASLMNA
SCHEMBL16547629 0.89 KRAS (0.57) TNFRSF1AABCG2ABCB1ALDH1A1KRAS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3039013-A1 PYRAZOLOCHALCONES AS POTENTIAL ANTICANCER AGENTS Council of Scientific and Industrial Research (IN) 2016-07-06 — — EP claimed
WO-2015029051-A1 PYRAZOLOCHALCONES AS POTENTIAL ANTICANCER AGENTS COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2015-03-05 — — WO claimed
EP-3039013-B1 PYRAZOLOCHALCONES AS POTENTIAL ANTICANCER AGENTS COUNCIL SCIENT IND RES (IN) 2018-09-12 — — EP disclosed
US-9604933-B2 Pyrazolochalcones as potential anticancer agents COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2017-03-28 — — US disclosed
US-20160207888-A1 PYRAZOLOCHALCONES AS POTENTIAL ANTICANCER AGENTS COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2016-07-21 — — US disclosed
EP-3039013-A1 PYRAZOLOCHALCONES AS POTENTIAL ANTICANCER AGENTS Council of Scientific and Industrial Research (IN) 2016-07-06 — — EP disclosed
WO-2015029051-A1 PYRAZOLOCHALCONES AS POTENTIAL ANTICANCER AGENTS COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2015-03-05 — — WO disclosed
WO-2015029051-A1 PYRAZOLOCHALCONES AS POTENTIAL ANTICANCER AGENTS COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2015-03-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160207888-A1 PYRAZOLOCHALCONES AS POTENTIAL ANTICANCER AGENTS HCCS, CCNE2, FOXO3 TNFRSF1A 2780/4885MEN1 2405/4885KMT2A 2014/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback